Literature DB >> 3370594

Survival rates among patients with cancer in Alberta in 1974-78.

Y Mao1, R Semenciw, H Morrison, M Koch, G Hill, M Fair, D Wigle.   

Abstract

We calculated 5-year crude and relative survival rates, by age and sex, for patients in Alberta in whom cancer was diagnosed between 1974 and 1978. Cancers with low overall 5-year relative survival rates (less than 35%) included stomach cancer, cancer of the pancreas, lung cancer, brain cancer, multiple myeloma and myeloid leukemia. Cancers with high overall 5-year relative survival rates (more than 70%) included melanoma, breast cancer, cancer of the uterus, cancer of the bladder and Hodgkin's disease. Five-year relative survival rates were generally lower in the highest age group (75 years or more). A strong inverse relation between age and survival was noted for brain cancer, non-Hodgkin's lymphoma, Hodgkin's disease and myeloid leukemia.

Entities:  

Mesh:

Year:  1988        PMID: 3370594      PMCID: PMC1267941     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  5 in total

1.  The relative survival rate: a statistical methodology.

Authors:  F EDERER; L M AXTELL; S J CUTLER
Journal:  Natl Cancer Inst Monogr       Date:  1961-09

2.  Maximum utilization of the life table method in analyzing survival.

Authors:  S J CUTLER; F EDERER
Journal:  J Chronic Dis       Date:  1958-12

3.  A generalized iterative record linkage computer system for use in medical follow-up studies.

Authors:  G R Howe; J Lindsay
Journal:  Comput Biomed Res       Date:  1981-08

4.  Cancer patient survival: Surveillance, Epidemiology, and End Results Program, 1973-79.

Authors:  L G Ries; E S Pollack; J L Young
Journal:  J Natl Cancer Inst       Date:  1983-04       Impact factor: 13.506

5.  Cancer mortality associated with the high-temperature oxidation of nickel subsulfide.

Authors:  R S Roberts; J A Julian; D C Muir; H S Shannon
Journal:  IARC Sci Publ       Date:  1984
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.